Zogenix to Participate in Stifel 2014 Healthcare Conference

SAN DIEGO, Nov. 12, 2014 (GLOBE NEWSWIRE) -- Zogenix, Inc. ZGNX, a pharmaceutical company developing and commercializing products for the treatment of pain-related conditions and central nervous system disorders, today announced that Zogenix management will present at the Stifel 2014 Healthcare Conference in New York, NY on November 18, 2014.

The presentation will be webcast live and archived for 30 days on Zogenix' Investor Relations website at ir.zogenix.com. Management will also be available to participate in one-on-one meetings at the conference.

About Zogenix

Zogenix, Inc. ZGNX is a pharmaceutical company committed to developing and commercializing therapies that address specific clinical needs for people living with pain-related conditions and CNS disorders who need innovative treatment alternatives to help them return to normal daily functioning.

FPR